Factory Directly Supply High Purity 99.0% Cagrilintide CAS 1415456-99-3

• Customization: Available
• Formula: C20h28n8o7
• EINECS: 00000
• Model NO.: Cagrilintide
• Certification: ISO14001
• Color: White
• Classification: Peptide
• Function: Promote Digestion and Appetite
• Appearance: Powder
• Transport Package: 10 Plastic Vials or Tube
• Specification: 5mg, 10mg
• Trademark: RunYan
• Origin: China
• Production Capacity: 100kg

Product Description

Factory Directly Supply High Purity 99.0% Cagrilintide  CAS1415456-99-3  
Description

Peptide Name:Cagrilintide 

Sequence:γ-Glu-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2(Disulfidebridge:cys4-cys9)

CAS Number:1415456-99-3

Molecular Formula:C194H312N54O59S2

Molecular Weight:4409.1

Category:  Pharmaceutical Peptide,Custom peptide,polypeptide synthesis

Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity.

 

Description

Cagrilintide is a pharmaceutical peptide and a novel long-acting acylated amylin analogue under development as a nonselective amylin receptor (AMYR) and calcitonin G-protein coupled receptor (CTR) agonist. Clinically, Cagrilintide leads to significant weight loss and reduction in food intake. Cagrilintide has potential for obesity research. Its appearance is white powder, and the storage environment needs to be in a low temperature environment. 

Specifications

Apperance: White to off-white powder

Purity(HPLC): ≥98.0%

Single Impurity: ≤2.0%

Acetate Content(HPLC): 5.0%~12.0%

Water Content (Karl Fischer): ≤10.0%

Peptide Content: ≥80.0%

Packing and Shipping: Low temperature, vacuum packing, accurate to mg as required.

 

 Note: All the peptides are just for Research & Lab use, not for Human use or  commercial sale;

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.